DKBmed Radio

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines for prevention of COVID-19. Topics: *Updates on the BA.2 subvariant *Who should get a second booster? And when? *What conditions and factors place people at higher risk for severe COVID? *Pre-exposure prophylaxis for COVID-19 prevention *Mitigating risk of disease progressionPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-26-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of MedicineMichael Angarone, DO, FIDSA, Associate Professor, Division of Infectious Diseases, Departments of Medicine and Medical Education at Northwestern University Feinberg School of Medicine

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendationsPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of MedicineDavid Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient burden, and lower community viral load. But for which patients is it suitable? Can it be used as pre-exposure prophylaxis? How does the promise of long-acting ART actually mean in practice?</p><p>Join us for this <em>e</em>HIV Review podcast, as Dr. Tanyaporn Wansom, Senior Infectious Diseases Consultant at Chayun Consulting in Bangkok Thailand, takes us to the clinic to answer some of these key questionsTake ourpost-testto claim CME credits.To read a companion newsletterclick here.

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2 Subvariant. Topics: *New boosters in the future? *Challenges of additional boosters *Cardiac concerns with COVID-19 vaccines? *Collateral effects from the pandemic *Latest news on BA.2 SubvariantPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-13-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Paul Auwaerter discusses what we learned from the COVID-19 pandemic. Topics: *Reviewing the timeline of events and variants *What happens next? *Preparing for the future *The new role of monoclonal antibodiesPost-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-24-22-episode/evalAccess our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialtyPresenting faculty:Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine